Ultragenyx Pharmaceutical | RARE - Azione

Prezzo Delle Azioni
23.12
Cambio Giornaliero
-0.03 -0.13%
Mensile
2.26%
Annuale
-31.82%
Q2 Previsione
21.77




Azione Cambiamento Data
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Alnylam Pharmaceuticals USD 82.72M 7.34M 2025-12
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Esperion Therapeutics USD 108.54M 5.93M 2025-09
Insmed USD 132.07M 11.1M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Kyowa Hakko Kirin JPY 72.86B 304M 2025-06
MacroGenics USD 7.91M 840K 2025-12
Moderna USD 332M 92M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
PTC Therapeutics USD 79.65M 26.96M 2025-12
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Sarepta Therapeutics USD 914.74M 162.42M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
Vertex Pharmaceuticals USD 1.69B 60M 2025-12